Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Beckhove

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Clinical Immunology (Orlando, Fla.)|September 19, 2017
Targeting immune modulatory pathways in cancerPhilipp Beckhove
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Immunology and immunotherapeutic approaches in multiple myelomaChristoph Schlude, Philipp Beckhove
Current Opinion in Oncology|September 23, 2009
Current developments with peptide-based human tumor vaccinesKhashayarsha Khazaie, Andreas Bonertz, Philipp Beckhove
Immunology and Cell Biology|December 15, 2010
CD40L co-stimulation from CD8+ to CD4+ effector memory T cells supports CD4+ expansionMaria Xydia, Yingzi Ge, Ulrike Quitsch, et al.
International Journal of Oncology|October 30, 2014
Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical studyVolker Schirrmacher, Christoph Schlude, Jürgen Weitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cellsJochen Schwendemann, Carmen Choi, Volker Schirrmacher, et al.
Cancer Cell|June 11, 2024
Hand in hand to successful immunotherapy: CD8<sup>+</sup> T cells and M1-like macrophages swap the batonAbir Hussein, Slava Stamova, Maria Xydia, et al.
Pulmonology|January 8, 2025
Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study. Authors´replySeyer Safi, Axel Benner, Philipp Beckhove, et al.
Immunology|June 11, 2005
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cellsYolanda D Mahnke, Jochen Schwendemann, Philipp Beckhove, et al.
Anticancer Research|May 13, 2015
Endothelial Cells Derived from Non-malignant Tissues Are of Limited Value as Models for Brain Tumor VasculatureJennifer Lohr, Andreas Mock, Philipp Beckhove, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Clinical Immunology (Orlando, Fla.)|September 19, 2017
Targeting immune modulatory pathways in cancerPhilipp Beckhove
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Immunology and immunotherapeutic approaches in multiple myelomaChristoph Schlude, Philipp Beckhove
Current Opinion in Oncology|September 23, 2009
Current developments with peptide-based human tumor vaccinesKhashayarsha Khazaie, Andreas Bonertz, Philipp Beckhove
Immunology and Cell Biology|December 15, 2010
CD40L co-stimulation from CD8+ to CD4+ effector memory T cells supports CD4+ expansionMaria Xydia, Yingzi Ge, Ulrike Quitsch, et al.
International Journal of Oncology|October 30, 2014
Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical studyVolker Schirrmacher, Christoph Schlude, Jürgen Weitz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cellsJochen Schwendemann, Carmen Choi, Volker Schirrmacher, et al.
Cancer Cell|June 11, 2024
Hand in hand to successful immunotherapy: CD8<sup>+</sup> T cells and M1-like macrophages swap the batonAbir Hussein, Slava Stamova, Maria Xydia, et al.
Pulmonology|January 8, 2025
Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study. Authors´replySeyer Safi, Axel Benner, Philipp Beckhove, et al.
Immunology|June 11, 2005
Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cellsYolanda D Mahnke, Jochen Schwendemann, Philipp Beckhove, et al.
Anticancer Research|May 13, 2015
Endothelial Cells Derived from Non-malignant Tissues Are of Limited Value as Models for Brain Tumor VasculatureJennifer Lohr, Andreas Mock, Philipp Beckhove, et al.
Pageof 14